Domov › Metastatski rak › Indiana › Indianapolis
Klinične študije za Metastatski rak v Indianapolis, IN
19 študij za Metastatski rak išče udeležence na lokacijah v Indianapolis in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Vključevanje udeležencevFaza 1
- IU Simon Cancer Center, Indianapolis
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Indiana University Simon Comprehensive Cancer Center, Indianapolis
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Vključevanje udeležencevFaza 3
- Franciscan Health, Indianapolis
- Franciscan Health Mooresville, Mooresville · 16 mi stran
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Community Health Network, Inc, Indianapolis
- Community Health Network, Inc., Indianapolis
- Community Health Network, Inc., Indianapolis
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Vključevanje udeležencevFaza 3
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
- Franciscan Health, Indianapolis
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Vključevanje udeležencevFaza 3
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
- Franciscan Health, Indianapolis
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Vključevanje udeležencevFaza 3
- Indiana University Health University Hospital, Indianapolis
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Vključevanje udeležencevFaza 1/2
- Community Health Network, Indianapolis
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
Vključevanje udeležencevFaza 1
- Community Health Network MD Anderson Cancer Center - North, Indianapolis
Prospective Validation of a Points Score System Predicting 30-day Survival
Vključevanje udeležencevOpazovalna študija
- Methodist Hospital, Indianapolis
- IU Health West, Avon · 13 mi stran
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
- Franciscan Health, Indianapolis
- Community Cancer Center North, Indianapolis
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Community Cancer Center North, Indianapolis
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Vključevanje udeležencevFaza 1
- Indiana University (IU) Melvin and Bren Simon Cancer Center, Indianapolis
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Community Health Network, Indianapolis
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Vključevanje udeležencevFaza 3
- Research Site, Indianapolis
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Vključevanje udeležencevFaza 3
- Franciscan Health Indianapolis, Indianapolis
A Study of LY4175408 in Participants With Advanced Cancer
Vključevanje udeležencevFaza 1
- Community Health Network, Indianapolis
Evaluating Disparities in Precision Oncology
Vključevanje udeležencevOpazovalna študija
- Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Vključevanje udeležencevFaza 2/3
- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Študije za Metastatski rak v drugih mestih
- Houston, TX104 študij
- New York City, NY93 študij
- Nashville, TN70 študij
- Boston, MA63 študij
- Los Angeles, CA57 študij
- St. Louis, MO54 študij
- Arlington, VA53 študij
- Philadelphia, PA46 študij
- Chicago, IL45 študij
- San Antonio, TX44 študij
- Washington, DC43 študij
- Dallas, TX42 študij
Druge študije v Indianapolis
- Nemalicelični pljučni rak32 študij
- Rak (vse vrste)24 študij
- Srčno popuščanje23 študij
- Debelost20 študij
- Rak dojke20 študij
- Kolorektalni rak18 študij
- Rak jajčnikov17 študij
- Srčno-žilne bolezni17 študij
- Rak pljuč16 študij
- Sladkorna bolezen tipa 114 študij
- Rak endometrija14 študij
- Alzheimerjeva bolezen14 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.